Targeted prostate cancer screening could benefit men with inherited cancer syndrome Read more New BRCA-targeting drug could offer hope in treating advanced prostate cancer Read more Cells from the centre of tumours most likely to spread around the body Read more herePreviousNext Highlights Research is key to future treatment Our six research themes and two cross-cutting themes bring together a critical mass of internationally renowned clinicians, scientists and allied health professionals, allowing us to ensure that novel diagnostics and physical and systemic therapies are rapidly available to all cancer patients. Patient and public involvement and engagement Involving patients and the public with our research ensures that we focus on the issues that matter most to those affected by cancer. Find out more Latest news Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers An immunotherapy combination could be better than standard ‘Extreme’ chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests. Find out more 'Gut bugs' can drive prostate cancer growth and treatment resistance Common gut bacteria can fuel the growth of prostate cancers and allow them to evade the effects of treatment, a new study finds. Find out more Scientists use AI to identify new drug combination for children with incurable brain cancer Scientists have used artificial intelligence-enhanced tools to successfully propose a new combination of drugs for use against an incurable childhood brain cancer. Find out more More information Upcoming events Patient and public involvement and engagement BRC training hub Magazine articles Follow us on Twitter
